| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alessandro Cagol, Charidimos Tsagkas, Cristina Granzier. Advanced Brain Imaging in Central Nervous System Demyelinating Diseases. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942520. |
this review delves into state-of-the-art modalities applied to multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| Massimo Filippi, Paolo Preziosa, Monica Margoni, Maria A Rocc. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942518. |
diagnostic criteria for multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein-immunoglobulin g-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| Massimo Filippi, Paolo Preziosa, Monica Margoni, Maria A Rocc. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942518. |
neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein-immunoglobulin g-associated disease (mogad) are recognized as separate conditions from ms, with specific diagnostic criteria. |
2024-06-28 |
2024-07-01 |
Not clear |
| Bas Jaspers. Spinal Cord Imaging in Multiple Sclerosis and Related Disorders. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942523. |
the anatomical, pathologic, imaging and prognostic consideriations for the spinal cord for ms and the most important other demyelinating disorders, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease, are reviewed. |
2024-06-28 |
2024-07-01 |
Not clear |
| Àlex Rovira, Angela Vidal-Jordana, Cristina Auger, Jaume Sastre-Garrig. Optic Nerve Imaging in Multiple Sclerosis and Related Disorders. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942524. |
optic neuritis is a common feature in multiple sclerosis and in 2 other autoimmune demyelinating disorders such as aquaporin-4 igg antibody-associated neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| Mark M Magharious, Melike Pekmezci, Mark D Mamlouk, Jonathan C Horton, Marc H Levi. Revised Diagnosis From Histiocytic Neoplasm to Optic Chiasm Glioblastoma After Genetic Analysis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-06-27. PMID:38926909. |
serologic testing (including myelin oligodendrocyte glycoprotein and neuromyelitis optica antibodies) and cerebrospinal fluid analysis were negative. |
2024-06-27 |
2024-06-29 |
Not clear |
| János György Pitter, László Nagy, Balázs Nagy, Rok Hre. Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront. Journal of personalized medicine. vol 14. issue 6. 2024-06-27. PMID:38929820. |
development perspectives for curative technologies in primary demyelinating disorders of the central nervous system with neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) at the forefront. |
2024-06-27 |
2024-06-29 |
Not clear |
| János György Pitter, László Nagy, Balázs Nagy, Rok Hre. Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront. Journal of personalized medicine. vol 14. issue 6. 2024-06-27. PMID:38929820. |
primary demyelinating disorders of the central nervous system (cns) include multiple sclerosis and the orphan conditions neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein igg-associated disease (mogad). |
2024-06-27 |
2024-06-29 |
Not clear |
| O Fernández, X Montalbán, E Agüera, Y Aladro, A Alonso, R Arroyo, L Brieva, C Calles, L Costa-Frossard, S Eichau, J M García-Domínguez, M A Hernández, L Landete, M Llaneza, S Llufriu, J E Meca-Lallana, V Meca-Lallana, E Moral, J M Prieto, Ll Ramió-Torrentà, N Téllez, L Romero-Pinel, A Vilaseca, A Rodríguez-Antigüeda. [XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (I)]. Revista de neurologia. vol 79. issue 1. 2024-06-27. PMID:38934946. |
perspectives in demyelinating pathologies were reviewed, focusing on neuromyelitis optica and myelin oligodendrocyte glycoprotein antibody-associated disease, highlighting their pathophysiological and diagnostic differences compared to ms. advances in neuroimaging were also discussed, and especially the analysis of active chronic lesions, such as paramagnetic rim lesions. |
2024-06-27 |
2024-06-29 |
Not clear |
| Wenjing Luo, Xiaonan Zhong, Shishi Shen, Ling Fang, Yiying Huang, Yuge Wang, Wei Qi. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. European journal of neurology. 2024-06-12. PMID:38863307. |
a comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. |
2024-06-12 |
2024-06-14 |
Not clear |
| Wenjing Luo, Xiaonan Zhong, Shishi Shen, Ling Fang, Yiying Huang, Yuge Wang, Wei Qi. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. European journal of neurology. 2024-06-12. PMID:38863307. |
we aimed to characterize hypothalamic involvement in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and compare it with neuromyelitis optica spectrum disorder (nmosd) and multiple sclerosis (ms). |
2024-06-12 |
2024-06-14 |
Not clear |
| Yuqing Wu, Hao Zhou, Xiaojiao Ci, Jie L. Low T3 syndrome is associated with the severity of myelin oligodendrocyte glycoprotein antibody-associated disease exacerbation. Frontiers in neuroscience. vol 18. 2024-06-05. PMID:38835837. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a rare autoimmune inflammatory disease of the central nervous system, (cns) different from multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2024-06-05 |
2024-06-07 |
Not clear |
| Caterina Lapucci, Vincenzo Daniele Boccia, Thoma Dario Clementi, Simona Schiavi, Luana Benedetti, Antonio Uccelli, Giovanni Novi, Maria Cellerino, Matilde Ingles. Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2024-06-04. PMID:38831519. |
brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease. |
2024-06-04 |
2024-06-06 |
Not clear |
| Caterina Lapucci, Vincenzo Daniele Boccia, Thoma Dario Clementi, Simona Schiavi, Luana Benedetti, Antonio Uccelli, Giovanni Novi, Maria Cellerino, Matilde Ingles. Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2024-06-04. PMID:38831519. |
neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) diagnosis are based on the presence of serological and magnetic resonance imaging (mri) biomarkers. |
2024-06-04 |
2024-06-06 |
Not clear |
| Sümeyye Koç, Sedat Şen, Yüksel Terzi, Ferah Kızılay, Serkan Demir, Dürdane Bekar Aksoy, Fatma Kurtuluş, Nuray Bilge, Egemen Idilman, Cihat Uzunköprü, Serdal Güngör, Vedat Çilingir, Özlem Ethemoğlu, Cavit Boz, Haluk Gümüş, Ahmet Kasım Kılıç, Ayşin Kısabay, Levent Sinan Bir, Ömer Faruk Turan, Aysun Soysal, Mesrure Köseoğlu, Gülnur Tekgöl Uzuner, Hasan Bayındır, Sibel Canbaz Kabay, Mustafa Çam, Vildan Yayla, Hüseyin Tan, Abdülcemal Özcan, Özlem Taşkapıoğlu, Muammer Korkmaz, Yusuf Tamam, Yılmaz İnanç, Hüsnü Efendi, Dilcan Kotan, Mehmet Fatih Yetkin, Adnan Burak Bilgiç, Hikmet Saçmacı, Serpil Demirci, Yahya Çelik, Turan Poyraz, Murat Terz. Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein. Balkan medical journal. 2024-06-03. PMID:38828767. |
optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (nmosd) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin g (anti-mog-igg). |
2024-06-03 |
2024-06-05 |
Not clear |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Samira Luisa Apostolos Pereira, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Pröbstel, Cristina Granziera, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefan. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of neurology. 2024-05-23. PMID:38780377. |
grey matter atrophy and its relationship with white matter lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, and multiple sclerosis. |
2024-05-23 |
2024-05-27 |
Not clear |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Samira Luisa Apostolos Pereira, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Pröbstel, Cristina Granziera, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefan. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of neurology. 2024-05-23. PMID:38780377. |
to evaluate: (1) the distribution of gray matter (gm) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4+nmosd), and relapsing-remitting multiple sclerosis (rrms); and (2) the relationship between gm volumes and white matter lesions in various brain regions within each disease. |
2024-05-23 |
2024-05-27 |
Not clear |
| Ying Chen, Jingzi Zhangbao, Junfeng Xu, Lei Zhou, Zhiming Zhou, Chao Qua. The distinction of area postrema syndrome between MOGAD and NMOSD. Heliyon. vol 10. issue 10. 2024-05-23. PMID:38779012. |
both myelin oligodendrocyte glycoprotein-igg associated disorders (mogad) and neuromyelitis optica spectrum disorder (nmosd) are demyelinating diseases of the central nervous system. |
2024-05-23 |
2024-05-27 |
Not clear |
| Niroshan Jeyakumar, Magdalena Lerch, Russell C Dale, Sudarshini Ramanatha. MOG antibody-associated optic neuritis. Eye (London, England). 2024-05-23. PMID:38783085. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is a demyelinating disorder, distinct from multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2024-05-23 |
2024-05-27 |
Not clear |
| Aiden Haghikia, Georg Schett, Dimitrios Mougiakako. B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases. The Lancet. Neurology. vol 23. issue 6. 2024-05-17. PMID:38760099. |
neuroimmunology research and development has been marked by substantial advances, particularly in the treatment of neuroimmunological diseases, such as multiple sclerosis, myasthenia gravis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein antibody disease. |
2024-05-17 |
2024-05-27 |
Not clear |